Published on 10 Nov 2022 on Zacks via Yahoo Finance
Immuneering Corporation (IMRX) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to loss of $0.47 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -2.08%. A quarter ago, it was expected that this company would post a loss of $0.52 per share when it actually produced a loss of $0.44, delivering a surprise of 15.38%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.